Simcenter Culgi revolutionizes drug discovery! This Siemens Xcelerator component uses AI-ready computational chemistry and advanced multiscale modeling to accelerate molecule and formulation screening, reducing experiments and improving preclinical research.
July 10, 2026
Sponsored by
Simcenter Culgi, part of Siemens Xcelerator, addresses critical drug discovery challenges by enabling rapid molecule and formulation screening. It provides a sophisticated computational chemistry solution that structures scientific work as AI-ready knowledge, facilitating AI-powered, simulation-driven discovery with full traceability. By using advanced multiscale in silico modeling, Simcenter Culgi determines drug molecule behavior in complex environments, reducing costly physical experiments, expanding design space exploration, and ultimately leading to improved first-in-human outcomes in preclinical research.
